Skip to main content
. Author manuscript; available in PMC: 2026 Jun 5.
Published before final editing as: J Addict Med. 2025 Nov 25:10.1097/ADM.0000000000001616. doi: 10.1097/ADM.0000000000001616

TABLE 2.

Characteristics of Adolescent-only Serving Substance Use Treatment Facilities Associated With Offering Nicotine Replacement Therapies and Non-nicotine Replacement Therapies

Adolescent-only Facilities; n = 367 (2.6%)*
NRT (n = 62) Non-NRT (n = 54)
Characteristic n (%)† Multivariate Odds Ratios; aOR (95% CI)‡ P n (%)† Multivariate Odds Ratios; aOR (95% CI)‡ P
Treatment Focus
 Substance use treatment focus only 25 (14.5) Reference Reference 20 (11.6) Reference ref
 Mixed substance use and mental health focus 37 (19.0) 0.89 (0.42, 1.9) 0.77 34 (17.4) 1.33 (0.61, 2.88) 0.476
Ownership
 Private, for-profit 13 (18.1) Reference Reference 11 (15.3) Reference ref
 Private, non-profit 43 (17.0) 2.14 (0.68, 6.77) 0.194 36 (14.2) 1.42 (0.44, 4.58) 0.56
 State/local/federal/tribal govt 6 (14.3) 1.16 (0.28, 4.89) 0.838 7 (16.7) 1.28 (0.29, 5.68) 0.741
Region
 Northeast 11 (44.0) Reference Reference 5 (20.0) Reference ref
 Midwest 15 (25.4) 0.32 (0.08, 1.25) 0.102 13 (22.0) 1.29 (0.3, 5.63) 0.732
 South 10 (11.4) 0.18 (0.03, 0.9) 0.037 10 (11.4) 1.54 (0.29, 8.19) 0.61
 West 26 (13.3) 0.22 (0.06, 0.83) 0.026 26 (13.3) 1.02 (0.25, 4.11) 0.977
Integrated primary-care
 No 36 (12.3) Reference Reference 25 (8.9) Reference ref
 Yes 26 (34.7) 3.82 (1.67, 8.74) 0.002 29 (38.7) 6.51 (2.89, 14.65) < 0.001
Accepts Medicaid
 No 10 (9.4) Reference Reference 7 (6.6) Reference ref
 Yes 52 (19.9) 0.64 (0.19, 2.19) 0.482 47 (18.0) 1.42 (0.37, 5.4) 0.608
Accepts private insurance
 No 2 (1.4) Reference Reference 4 (2.7) Reference ref
 Yes 60 (27.2) 25.25 (5.09, 125.16) < 0.001 50 (22.6) 7.89 (2.35, 26.5) 0.001
Medicaid expanded state
 No 9 (13.6) Reference Reference 8 (12.1) Reference ref
 Yes 53 (17.6) 1.57 (0.44, 5.55) 0.488 46 (15.3) 2.48 (0.68, 9.09) 0.171
Outpatient substance use treatment
 No 29 (39.7) Reference Reference 24 (32.9) Reference ref
 Yes 33 (11.2) 0.57 (0.19, 1.68) 0.305 30 (10.2) 0.8 (0.25, 2.54) 0.709
Inpatient substance use treatment
 No 55 (15.7) Reference Reference 49 (14.0) — —
 Yes 7 (41.2) 2.31 (0.63, 8.41) 0.205 5 (29.4) 2.28 (0.61, 8.48) 0.221
Residential substance use treatment
 No 25 (9.7) Reference Reference 22 (8.6) Reference ref
 Yes 37 (33.6) 2.16 (0.75, 6.25) 0.156 32 (29.1) 2.79 (0.9, 8.67) 0.076
Screening for tobacco use
 No 5 (7.8) Reference Reference 1 (1.6) Reference ref
 Yes 57 (18.8) 1.51 (0.44, 5.23) 0.514 53 (17.5) 11.72 (1.40, 98.06) 0.023
Education and counseling for smoking/tobacco cessation
 No 5 (4.9) Reference Reference 7 (6.8) Reference ref
 Yes 57 (21.6) 6.36 (2.09, 19.34) 0.001 47 (17.8) 2.23 (0.77, 6.45) 0.137
Vaping policy
 Not allowed 55 (17.1) Reference Reference 46 (14.3) Reference ref
 Allowed 7 (15.6) 0.61 (0.06, 5.77) 0.664 8 (17.8) 2.5 (0.12, 51.84) 0.553
Smoking policy
 Not allowed 52 (16.7) Reference Reference 45 (14.5) Reference ref
 Allowed 10 (17.9) 2.17 (0.28, 16.67) 0.457 9 (16.1) 0.8 (0.05, 14.19) 0.882

Bold indicates statistical significance P < 0.05. Bold indicates statistical significance P < 0.005.

*

Includes facilities serving only patients who meet the AAP definition of adolescence (11–21 y).

†

Percentages are calculated out of a denominator of number of facilities that have the characteristic.

‡

Odds ratios are estimated using multivariable logistic regression models controlling for and ownership (private for-profit, private not-for-profit or government owned), treatment focus (substance use or both substance use and mental health), accepted insurances, treatment setting (inpatient, outpatient, or residential), integrated primary-care programs, smoking-policies, vaping-policies, tobacco use screening and counseling, US census region, and state Medicaid-expansion status.

NRT indicates nicotine replacement therapy; aOR, adjusted odds ratio.